Literatur
-
1
Andrews N P, Fogel R I, Pelargonio G, Evans J J, Prystowsky E N.
Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia.
J Am Coll Cardiol.
1999;
34
2023-2030
-
2
Antzelevitch C, Brugada P, Borggrefe M. et al .
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
Circulation.
2005;
111
659-670 (Erratum in: Circulation 2005; 112(4): e74)
-
3
Bardy G H, Lee K L, Mark D B. et al .
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med.
2005;
352
225-237
-
4
Bigger Jr. J T . Coronary Artery Bypass Graft (CABG) Patch Trial Investigators .
Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.
N Engl J Med.
1997;
337
1569-1575
-
5
Bristow M R, Saxon L S, Boehmer J. et al .
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med.
2004;
350
2140-2150
-
6
Coggins D L, Lee R J, Sweeney J. et al .
Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin.
J Am Coll Cardiol.
1994;
23
1333-1341
-
7
Connolly S J, Gent M, Roberts R S. et al .
Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone.
Circulation.
2000;
101
1297-1302
-
8
Connolly S J, Hallstrom A P, Cappato R. et al .
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study.
Eur Heart J.
2000;
21
2071-2078
-
9
Gaita F, Giustetto C, Bianchi F. et al .
Short QT Syndrome: a familial cause of sudden death.
Circulation.
2003;
108
965-970
-
10
Gonska B D, Cao K, Schaumann A, Dorszewski A, von zur Mühlen F, Kreuzer H.
Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: results and long-term follow-up.
J Am Coll Cardiol.
1994;
24
1506-1514
-
11
Haissaguerre M, Extramiana F, Hocini M. et al .
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.
Circulation.
2003;
108
925-928
-
12
Hohnloser S H, Kuck K H, Dorian P. et al .
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.
N Engl J Med.
2004;
351
2481-2488
-
13
Jung W, Andresen D, Block M. et al .
Leitlinien zur Implantation von Defibrillatoren.
Clin Res Cardiol.
2006;
95
696-708
-
14
Knight B P, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger S A.
Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
J Am Coll Cardiol.
1999;
33
1964-1970
-
15
Kuck K H, Cappato R, Siebels J, Ruppel R.
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH).
Circulation.
2000;
102
748-754
-
16
Maron B J, McKenna W J, Danielson G K. et al .
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.
Eur Heart J.
2003;
24
1965-1991
-
17
Mirowski M, Reid P R, Mower M M. et al .
Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.
N Engl J Med.
1980;
303
322-324
-
18
Moss A J, Zarebra W, Hall W J. et al .
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
N Engl J Med.
2002;
346
877-883
-
19
Pacifico A, Hohnloser S H, Williams J H. et al .
Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.
N Engl J Med.
1999;
340
1855-1862
-
20
Priori S G, Aliot E, Blomstrom-Lundqvist C. et al .
Update of the guidelines on sudden cardiac death of the European Society of Cardiology.
Eur Heart.
2003;
24
13-15
-
21
Schron E B, Exner D V, Yao Q. et al .
Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks.
Circulation.
2002;
105
589-594
-
22
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators .
A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias.
N Engl J Med.
1997;
337
1576-1583
-
23
Wichter T, Paul M, Wollmann C. et al .
Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
Circulation.
2004;
109
1503-1508
-
24
Zareba W, Moss A J, Daubert J P, Hall W J, Robinson J L, Andrews M.
Implantable cardioverter defibrillator in high-risk long QT syndrome patients.
J Cardiovasc Electrophysiol.
2003;
14
337-341
-
25
Zipes D P, Camm A J, Borggrefe M. et al .
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
J Am Coll Cardiol.
2006;
48
e247-e346
Prof. Dr. Dirk Böcker
St. Marien-Hospital Hamm
Knappenstr. 19
59071 Hamm
Email: Dirk.Boecker@Marienhospital-Hamm.de
